AzTrials
AzTrials

Coronavirus InfectionCOREGNCT04508959

The McMaster Multi-Regional COVID-19 Hospital Case Registry

An observational study of Coronavirus Infection and Coronavirus, run by McMaster University at 5 sites in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The McMaster Multi-Regional Hospital Coronavirus Registry (COREG) is a platform that is collecting detailed case data on laboratory confirmed COVID-19 hospital inpatients and outpatients. Read more about this study

Who is it for?
Ages 18 years and older
How many people
1,500 participants
Where
5 sitesCanada
Study dates
15 Apr 2020to Jul 2021
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: * Persons tested positive for SARS-CoV-2 using hospital facilities * Patients seen or admitted with confirmed COVID-19 to the hospital

Who may be able to join

  • Persons tested positive for SARS-CoV-2 using hospital facilities
  • Patients seen or admitted with confirmed COVID-19 to the hospital

Who cannot join

  • The pragmatic nature of the registry warrants the broadest inclusion criteria that are feasible. In keeping with the pragmatic nature of this registry, no exclusions are introduced.

Trial locations and contacts

5 sites in 1 country.

Andrew P Costa, PhD contact

5197296285

acosta@mcmaster.ca

Darly Dash, MSc contact

dashd@mcmaster.ca

5 sites in 1 country

Canada5 sites, 5 recruiting
  • Hamilton General Hospital

    Hamilton, Ontario, L8L2X2

    Mats L Junek, MD, MSc, mats.junek@medportal.ca

    Recruiting
  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, L9C0E3

    Jessica Kapralik, MD (PGY5), jessica.kapralik@medportal.ca

    Recruiting
  • Grand River Hospital

    Kitchener, Ontario, N2G1G3

    Tyler Pitre, MA, MD (PGIM), tyler.pitre@medportal.ca

    Recruiting
  • St. Mary's General Hospital

    Kitchener, Ontario, N2M1B2

    Tyler Pitre, MA, MD (PGIM), tyler.pitre@medportal.ca

    Recruiting
  • Niagara Health System

    St. Catharines, Ontario, L2S0A9

    Lisa Patterson, lisa.patterson@niagarahealth.on.ca

    Recruiting

Other trials in Canada

About this study

Official title: A Rapid Research Platform to Inform Prevention & Improve the Clinical Management of COVID-19 Illness for Priority Older Adult Groups: The McMaster Multi-regional Hospital Coronavirus Registry

The McMaster Multi-Regional Hospital Coronavirus Registry (COREG) is a platform that is collecting detailed case data on laboratory confirmed COVID-19 hospital inpatients and outpatients. The COREG platform will provide rapid high-quality evidence to improve the prevention and clinical management of COVID-19 for older adults in Canada, and internationally. The COREG platform will also provide researchers and partners with complete regional level clinical data on COVID-19 cases to inform rapid decision-making and projections, sub-studies, extensions, and linkage for all affected populations.

Read the detailed description

Rationale: The novel coronavirus disease of 2019 (COVID-19) is a rapidly evolving pandemic, which poses a major and ongoing threat to health and the health system both globally and locally. While there have been country-specific case series that have offered some guidance on interventions that may be effective; applying them to local settings is problematic, given differences in population density, demographics (including vulnerable sub-populations), economic and political capacity. To this end, local data is needed to better inform on the timing and implementation of specific and targeted interventions to mitigate the spread and impact of the virus immediately, and thereafter. Near real-time information can greatly inform efforts and decisions needed to address resource allocation in response to the dynamic pandemic.

Objectives: The Investigators' aim is to collect data on the impact and burden of COVID-19 that can inform and support real-time local clinical and policy decisions. Specifically, the objectives are to: 1) Create a COVID-19 admission case registry as a local research and quality improvement platform for the COVID-19 pandemic; and 2) Collect data that can inform local pandemic decisions and evaluation, including incidence, vulnerability, complications, and clinical course of COVID-19 patients.

Methods: The investigators have established the McMaster Coronavirus (COVID-19) Registry (COREG), an ISARIC-WHO compatible, comprehensive platform that facilitates uniform data collection of COVID-19. COREG is an extension of the ISARIC-WHO case report form (CRF) designed to capture local information on transmission, disease- burden, course, and outcomes of COVID-19 cases from all COVID-19 charting hospitals in the Waterloo, Hamilton, and Niagara Regions of Ontario, Canada (Population > 1,500,000). COREG is a comprehensive patient registry based retrospective data collection on all suspected and confirmed COVID-19 cases (according to the ISARIC definition) admitted to St. Joseph's Healthcare Hamilton (SJHH), Hamilton Health Sciences (HHS), Grand River Hospital, St. Mary's General Hospital, and the Niagara Health System. The registry includes data abstracted from existing chart data generated during routine clinical care. A waiver of informed consent is granted. Data categories to be collected follow the ISARIC-WHO CRF (https://isaric.tghn.org/covid-19-clinical-research-resources/) and include demographics, co-morbidities, pre-admission medications, signs and symptoms, diagnostic results, in-hospital interventions and health outcomes (medical complications during hospitalization including ICU and death). Cases are identified by the Infection Prevention and Control (IPAC) at each site and records will be accessed remotely and securely by research and medical staff. Extracted data are stored in a secure McMaster hosted REDCap and data server. Data collectors undergo a standardized training. Weekly governance meetings occur between the data collectors, operational leads and clinical site lead at each site to discuss, address and resolve any barriers and inconsistences in data collection and advance the scientific agenda.

Impact: COREG ensures that COVID-19 data collected are standardized and robust and will have a meaningful impact on local decision-making, while also being comparable internationally. COREG will shape consensus recommendations on inpatient management of hospitalized patients with COVID-19. It will be invaluable to local and global research efforts, since linkage to tissue biobanks and other administrative databases can be easily performed to address questions on pathophysiology, long-term outcomes and healthcare burden.

Keywords
Registry
Medical subject headings
Coronavirus Infections, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04508959
Study groupRoleWhat they receive
Screened patientsAll individuals screened using the hospital's microbiology laboratory.
Outpatient (Emergency Department) casesAll individuals seen in the emergency department who test positive for COVID-19.
Inpatient (General Medical or Intensive Care) casesAll individuals admitted to a general or intensive care bed who test positive for COVID-19.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serious COVID-19 infection

    Defined as symptomatic hospital outpatients with laboratory confirmed SARS-CoV-2 (based on the ISARIC definition) through the COREG platform.

    Measured: through study completion, an average of 1 year

  2. Severe infection (requiring admission)

    Defined as persons admitted with laboratory confirmed SARS-CoV-2 (based on the ISARIC definition) available through the COREG platform. We will also conduct sub analyses of hospital acquired COVID-19 also captured in the COREG platform.

    Measured: through study completion, an average of 1 year

  3. COVID-19 related death

    Defined as persons who died with laboratory confirmed SARS-CoV-2 (based on the ISARIC definition) available through the COREG platform.

    Measured: through study completion, an average of 1 year

Secondary outcomes (3)
  1. Length of stay

    Days from admission to discharge.

    Measured: through study completion, an average of 1 year

  2. Complications

    New or increased severity of conditions and syndromes from pre-morbid state.

    Measured: through study completion, an average of 1 year

  3. Intensive interventions

    Rate of intensive interventions during hospital stay.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2020
  2. Study start15 Apr 2020
  3. Primary completionJul 2021 (estimated)
  4. Study completionJul 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,500 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT04508959
Sponsor's protocol ID
172754
Acronym
COREG
Status last verified
Nov 2020
First submitted
10 Aug 2020
Last updated
24 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: WHO-ISARIC COVID-19 database (https://isaric.tghn.org/covid-19-clinical-research-resources/).

Questions about this trial

What is this clinical trial studying?

An observational study of Coronavirus Infection and Coronavirus, run by McMaster University at 5 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrew P Costa, PhD (5197296285, acosta@mcmaster.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serious COVID-19 infection (time frame: through study completion, an average of 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in